APA (7th ed.) Citation

BM, H., RB, L., DY, L., LQ, H., ZC, J., ZK, S., . . . HF, W. (2026). High-frequency irreversible electroporation versus transurethral resection of the prostate for benign prostatic hyperplasia (GIANT): A single-centre, randomised, double-blind, phase 3, non-inferiority trial. EClinicalMedicine, 97, 104034. https://doi.org/10.1016/j.eclinm.2026.104034

Chicago Style (17th ed.) Citation

BM, He, et al. "High-frequency Irreversible Electroporation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia (GIANT): A Single-centre, Randomised, Double-blind, Phase 3, Non-inferiority Trial." EClinicalMedicine 97 (2026): 104034. https://doi.org/10.1016/j.eclinm.2026.104034.

MLA (9th ed.) Citation

BM, He, et al. "High-frequency Irreversible Electroporation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia (GIANT): A Single-centre, Randomised, Double-blind, Phase 3, Non-inferiority Trial." EClinicalMedicine, vol. 97, 2026, p. 104034, https://doi.org/10.1016/j.eclinm.2026.104034.